News
-
-
COMMUNIQUÉ DE PRESSE
The Limestone Boat Company Announces Additional Default Under Outstanding Debentures and Manufacturing Resumption Update
The Limestone Boat Company Limited announces default on debenture payments and provides business update on manufacturing operations in New Brunswick facilities -
-
COMMUNIQUÉ DE PRESSE
Western Alaska Minerals Announces Closing of Second and Final Tranche of Upsized Non-Brokered Private Placement
Western Alaska Minerals announces closing of second tranche of non-brokered private placement, raising aggregate gross proceeds of C$8,720,616.45; Proceeds to fund 2024 exploration program -
COMMUNIQUÉ DE PRESSE
Orlando Credit Union Awarded the 2023 Top Community Credit Union for North Florida Region
Orlando Credit Union receives recognition from SBA at the Florida Regional awards ceremony at The Citrus Club Orlando for its recent lending achievements, supporting small businesses and economic growth -
-
COMMUNIQUÉ DE PRESSE
Bausch Health Announces Updates Related to Norwich XIFAXAN Matters
Bausch Health and Salix Pharmaceuticals provide updates on litigation with Norwich Pharmaceuticals and potential generic version of XIFAXAN. Bausch Health to enforce intellectual property rights. Details on FDA approval process and patent infringement lawsuit -
COMMUNIQUÉ DE PRESSE
Sonnet BioTherapeutics Provides Fiscal Year 2024 Second Quarter and Year-to-Date Business and Earnings Update
Sonnet BioTherapeutics announces financial results and corporate updates including Phase 1 data on SON-1010 safety, net proceeds from tax program, and clinical trial progress on SON-080 for CIPN -
COMMUNIQUÉ DE PRESSE
NANOBIOTIX annonce l'acceptation par l'Agence américaine du médicament, la FDA, d'un protocole pour une nouvelle étude randomisée de Phase 2 évaluant NBTXR3 pour les patients atteints d'un cancer du poumon de stade trois
Nanobiotix annonce l'acceptation par la FDA d'un protocole pour une nouvelle étude de phase 2 sur NBTXR3 pour le cancer du poumon de stade III -
